// App-Quantinova.ai

3874 : Mass spectrometry imaging determines biomarkers of early adaptive precision drug resistance in lung cancer

Researchers

Presenter

  • Erin H. Seeley

Principal Investigators

  • Pamela S. Cantrell

  • Callee M. Walsh

  • Sijin Wen

  • Satoshi Komo

  • Xiaoliang Wu

  • Wei Zhang

  • Patrick C. Ma

Medical Centers

  • Protea Biosciences, Morgantown, WV

  • West Virginia University Cancer Institute, Morgantown, WV

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Microsatellite instability

Drug/Treatment

  • TAE684

Outcome

  • N/A

Study Design

  • Adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved